Scaling for Success: Establishing AAV Processes that Deliver

Capabilities
Recorded: October 2026
On-Demand Webinar Available by November 1
About our BioInnovate Webinar on AAV Processes
This webinar explores how both AAV platform processes and technology collaborations can help advance gene therapies.
We’ll discuss the considerations for assessing a viral vectors platform fit and the scalability of those processes, including a collaborative case study with Touchlight.
What You’ll Learn
By attending this webinar, you will learn:
- Insights into Touchlight’s cell-free DNA platform, including R&D and GMP manufacturing capabilities, and experience in supporting advanced therapy clinical programmes.
- How Doggybone DNA (dbDNA™) can increase AAV genome titres, improve full capsid percentages, and reduce impurity packaging.
- How Pharmaron’s scalable AAV platform enables seamless progression from early feasibility studies through manufacturing.
- The value of leveraging small-scale upstream models to accelerate process development while maintaining scalability.
- How collaboration with innovators and technology providers helps drive continuous platform evolution.
- A case study highlighting the impact of this collaborative, innovation-driven approach on AAV process development.